Fig. 4From: H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemiaH19 expression in the surveillance of AML. a H19 expression in different clinical stages (newly diagnosis, complete remission, and relapse time) of AML patients. b Dynamic change of H19 expression in the follow-up of seven paired AML patients during newly diagnosis, complete remission, to relapse timeBack to article page